Status:
UNKNOWN
Virtual Reality Combined With rTMS for the Treatment of Depression : a Randomized Clinical Trial.
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
the Treatment of Depression
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Depression is a mood disorder affecting an individual in its entirety, altering its emotional and intellectual functioning . The major form of depression is the most common psychiatric disorder in Wes...
Eligibility Criteria
Inclusion
- Criteria of resistant depression
- Age from 18 to 65 years old included.
- Primary diagnosis of major depression in subjects according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria.
- Informed consent and signed to participate in the study
Exclusion
- Pregnant woman, parturient and nursing mothers.
- Absence of DSM-5 criteria for depression in subjects.
- Refusal to participate in the study.
- Modification of drug treatment in the month preceding inclusion.
- History of neurological pathology, head trauma or mental retardation.
- Presence of an addictive comorbidity.
- Presence of a major organic pathological.
- Presence of a contra-indication to virtual reality
- Presence of intracerebral ferro-metallic material, cochlear implant, pacemaker
Key Trial Info
Start Date :
November 9 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 9 2019
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT03336788
Start Date
November 9 2016
End Date
November 9 2019
Last Update
November 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, France, 13354